X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (510) 510
dextromethorphan (466) 466
male (357) 357
pharmacology & pharmacy (328) 328
female (282) 282
adult (274) 274
phenotype (190) 190
index medicus (182) 182
dextromethorphan - urine (156) 156
middle aged (149) 149
cytochrome p-450 cyp2d6 - metabolism (144) 144
dextromethorphan - metabolism (141) 141
dextromethorphan - pharmacokinetics (117) 117
cyp2d6 (115) 115
pharmacokinetics (112) 112
cytochrome p-450 cyp2d6 - genetics (108) 108
cytochrome p-450 enzyme system - metabolism (92) 92
chemistry, analytical (89) 89
metabolism (85) 85
genotype (82) 82
urine (81) 81
dextrorphan (76) 76
dextromethorphan - administration & dosage (75) 75
adolescent (74) 74
cytochrome p-450 (74) 74
chromatography, high pressure liquid (71) 71
performance liquid-chromatography (71) 71
dextromethorphan - blood (70) 70
hydroxylation (69) 69
drug interactions (65) 65
metabolites (65) 65
debrisoquine (64) 64
dextrorphan - urine (62) 62
young adult (61) 61
administration, oral (60) 60
animals (59) 59
aged (56) 56
biochemical research methods (55) 55
polymorphism, genetic (55) 55
polymorphism (53) 53
reproducibility of results (52) 52
analysis (51) 51
o-demethylation (50) 50
in-vivo (49) 49
toxicology (48) 48
oxidation (45) 45
area under curve (44) 44
cytochrome p450 (44) 44
drugs (44) 44
plasma (42) 42
dextromethorphan - pharmacology (41) 41
inhibition (41) 41
cytochrome p-450 enzyme system - genetics (40) 40
pharmacogenetics (40) 40
pharmacology/toxicology (40) 40
cytochrome p-450 cyp3a (39) 39
research (39) 39
psychiatry (38) 38
rats (38) 38
antitussive agents - pharmacokinetics (37) 37
enzymes (37) 37
cross-over studies (36) 36
dextromethorphan - adverse effects (36) 36
in-vitro (36) 36
stimulants (36) 36
chromatography, high pressure liquid - methods (35) 35
mixed function oxygenases - metabolism (35) 35
sensitivity and specificity (35) 35
dextromethorphan - therapeutic use (34) 34
dose-response relationship, drug (34) 34
human plasma (34) 34
abuse (33) 33
dextrorphan - blood (33) 33
levorphanol - analogs & derivatives (33) 33
oxidation-reduction (33) 33
population (33) 33
drug-metabolism (32) 32
physiological aspects (32) 32
neurosciences (31) 31
sparteine (31) 31
time factors (31) 31
biomedicine (30) 30
biotransformation (30) 30
genetic-polymorphism (30) 30
mass spectrometry (29) 29
phenotyping (29) 29
antitussive agents - urine (28) 28
double-blind method (28) 28
dextrorphan - metabolism (27) 27
health aspects (27) 27
human liver-microsomes (27) 27
pediatrics (27) 27
quinidine (27) 27
antitussive agents - blood (26) 26
caffeine (26) 26
child (26) 26
cytochrome p-450 cyp2d6 inhibitors (26) 26
morphine (26) 26
pharmacology (26) 26
alleles (25) 25
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Annals of Surgery, ISSN 0003-4932, 08/2013, Volume 258, Issue 2, pp. 262 - 269
OBJECTIVE:We conducted a pharmacokinetic (PK) study and a pharmacodynamic (PD) study to assess whether Roux-en-Y gastric bypass (RYGB) surgery is associated... 
furosemide | oral cocktail | CYP3A | gastric bypass | drug metabolism | SURGERY | FATTY LIVER-DISEASE | WEIGHT-LOSS | TRENDS | P-GLYCOPROTEIN | OBESITY | INTESTINAL ADAPTATION | BARIATRIC SURGERY | ABSORPTION | HEPATIC STEATOSIS | Gastric Bypass | Diuretics - pharmacokinetics | Excitatory Amino Acid Antagonists - pharmacokinetics | Humans | Middle Aged | Tolbutamide - urine | Male | Caffeine - pharmacokinetics | Midazolam - urine | Anti-Ulcer Agents - pharmacokinetics | Young Adult | Hypoglycemic Agents - administration & dosage | Aged, 80 and over | Diuretics - urine | Diuretics - administration & dosage | Hypoglycemic Agents - pharmacokinetics | Administration, Oral | Furosemide - pharmacokinetics | Omeprazole - administration & dosage | Excitatory Amino Acid Antagonists - administration & dosage | Hypoglycemic Agents - urine | Omeprazole - urine | Central Nervous System Stimulants - pharmacokinetics | Midazolam - blood | Dextromethorphan - urine | Adolescent | GABA Modulators - urine | Central Nervous System Stimulants - urine | Dextromethorphan - administration & dosage | Furosemide - administration & dosage | Tolbutamide - administration & dosage | Tolbutamide - pharmacokinetics | Caffeine - administration & dosage | Omeprazole - blood | GABA Modulators - pharmacokinetics | Midazolam - administration & dosage | Anti-Ulcer Agents - blood | Chromatography, High Pressure Liquid | Case-Control Studies | Excitatory Amino Acid Antagonists - urine | Hypoglycemic Agents - blood | Tandem Mass Spectrometry | Biotransformation | Adult | Female | Dextromethorphan - pharmacokinetics | Furosemide - urine | Caffeine - urine | Caffeine - blood | GABA Modulators - administration & dosage | GABA Modulators - blood | Omeprazole - pharmacokinetics | Anti-Ulcer Agents - urine | Midazolam - pharmacokinetics | Anti-Ulcer Agents - administration & dosage | Dextromethorphan - blood | Excitatory Amino Acid Antagonists - blood | Tolbutamide - blood | Aged | Central Nervous System Stimulants - blood | Pharmacokinetics | Central Nervous System Stimulants - administration & dosage
Journal Article
Journal of Chromatography B, ISSN 1570-0232, 09/2012, Volume 904, pp. 121 - 127
Journal Article
Journal Article
Journal of Chromatography A, ISSN 0021-9673, 10/2012, Volume 1259, pp. 158 - 166
► Discovery of dextromethorphan and metabolites in surface water. ► Metabolic profiling to create standards for environmental analysis. ► Finding of... 
Metabolic profiling | Dextromethorphan | Liquid chromatography/quadrupole-time of flight mass spectrometry | Wastewater analysis | CHEMISTRY, ANALYTICAL | HUMAN PLASMA | PHARMACEUTICALS | WASTE-WATER | BIOCHEMICAL RESEARCH METHODS | Liquid chromatography | Metabolites | Mass spectrometry
Journal Article
Clinical Pharmacology & Therapeutics, ISSN 0009-9236, 11/2007, Volume 82, Issue 5, pp. 531 - 540
Journal Article
Frontiers in Pharmacology, ISSN 1663-9812, 05/2017, Volume 8, Issue MAY
Purpose: Asian populations have around 40-60% frequency of reduced function allele CYP2D6*10 compared to 1-2% in Caucasian populations. The wide range of... 
Genotype | Metabolic ratio | CYP2D610 | Phenotyping method | Polymorphism | ALLELES | polymorphism | SINGLE-POINT PLASMA | HUMAN CYTOCHROME-P450 2D6 | metabolic ratio | genotype | DEXTROMETHORPHAN | GENE | PHARMACOGENOMICS | phenotyping method | PHARMACOLOGY & PHARMACY | PCR
Journal Article
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2017, Volume 137, Issue 9, p. 1147
Journal Article